{
    "title": "Alcobra to stop testing sole drug for ADHD after study fails",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4128082/Alcobras-ADHD-drug-fails-late-stage-study.html",
    "date": "2017-01-17",
    "keywords": [
        "drug",
        "study",
        "adhd",
        "percent",
        "placebo",
        "trial",
        "alcobra",
        "gmt",
        "disorder",
        "latestage",
        "mdx",
        "measure",
        "company",
        "hold",
        "email",
        "jan",
        "ltd",
        "attention",
        "deficit",
        "hyperactivity",
        "value",
        "bell",
        "developer",
        "direction",
        "executive",
        "dr",
        "conference",
        "calladhd",
        "inattention",
        "andor",
        "hyperactivityimpulsivity",
        "development",
        "alcobraat",
        "adolescence",
        "benefit",
        "food",
        "administration",
        "month",
        "conduct",
        "sixmonth",
        "safety",
        "datathe",
        "regulator",
        "therapy",
        "september",
        "light",
        "dataabout",
        "treatment",
        "imposition",
        "tuesdayin",
        "impact",
        "adult",
        "analysis",
        "midstage",
        "condition",
        "range",
        "promise",
        "syndrome",
        "partner",
        "europe",
        "cash",
        "balance",
        "nasdaq",
        "premarket",
        "trading",
        "reporting",
        "grover",
        "bengaluru",
        "editing",
        "dcouto"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}